Top Pre-Market Gainers (DNDN, OPTC, AEG)
Dendreon Corporation (NASDAQ:DNDN) surged 5.89% to $36.88 in pre market trading hours. The Seattle biotech firm is asking the Food and Drug Administration to license 36 more workstations to produce cancer drug Provenge at a New Jersey plant. The FDA cleared the drug for marketing in April. All of the available data for Dendreon Corp’s [...]
Biotech Stocks Alert! (DNDN, MRX, JAZZ)
Dendreon Corporation (NASDAQ:DNDN) dropped 4.15% to $35.07. This week, the company posted a net loss of $79.3 million, or 56 cents per share, compared with a loss of $45.6 million, or 40 cents per share, a year ago. Excluding a litigation charge, Dendreon lost 47 cents a share for the quarter. Analysts on average expected [...]
Biotech Stocks Alert! (DNDN, MRX, JAZZ)
Dendreon Corporation (NASDAQ:DNDN) dropped 4.15% to $35.07. This week, the company posted a net loss of $79.3 million, or 56 cents per share, compared with a loss of $45.6 million, or 40 cents per share, a year ago. Excluding a litigation charge, Dendreon lost 47 cents a share for the quarter. Analysts on average expected [...]
Biotech Stocks Alert! (DNDN, MRX, JAZZ)
Dendreon Corporation (NASDAQ:DNDN) dropped 4.15% to $35.07. This week, the company posted a net loss of $79.3 million, or 56 cents per share, compared with a loss of $45.6 million, or 40 cents per share, a year ago. Excluding a litigation charge, Dendreon lost 47 cents a share for the quarter. Analysts on average expected [...]